Gensia Sicor GenESA cardiac stress testing system launches Sept. 15
This article was originally published in The Gray Sheet
Executive Summary
GENSIA SICOR GENESA CARDIAC STRESS TESTING SYSTEM LAUNCH commences Sept. 15 to targeted cardiologists following approval Sept. 12 for use in the diagnosis of coronary artery disease in conjunction with radionuclide myocardial perfusion imaging and echocardiography for patients who cannot exercise adequately. The company currently has a 25-person sales force and has plans to add five more reps before year-end. Gensia predicts that its sales team will reach 40 by the end of 1998.